PMID: 11930470Apr 5, 2002Paper

Improving compliance in your dyslipidemic patient: an evidence-based approach

Journal of the American Academy of Nurse Practitioners
D M Becker, J K Allen

Abstract

To synthesize the evidence from landmark clinical studies of lipid-lowering pharmacotherapy and nurse management of hyperlipidemia, discuss issues related to nonadherence, and proposes strategies for achieving long-term cholesterol control. All publications of lipid-lowering clinical trials related to pharmacotherapy for dyslipidemias were accessed from a thorough Medline Search and reviewed by two nurse experts. Randomized controlled studies provide compelling evidence that reduction of blood cholesterol with pharmacotherapy reduces both first and subsequent coronary events. Nonetheless, inadequate provider and patient adherence to guidelines for lipid lowering remains prevalent. Studies show that nurses provide safe and effective care for patients with abnormal lipids. This article assists nurse practitioners in playing an active role in the implementation of the National Cholesterol Education Program Adult Treatment Panel III Report to be released in Spring 2001, where a strong emphasis will be placed on multidisciplinary approaches and adherence.

References

Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Jan 1, 1991·Journal of Clinical Epidemiology·J F SteinerT S Inut
Mar 1, 1990·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M S Brown, J L Goldstein
Feb 1, 1983·American Journal of Public Health·D E MoriskyC R Smith
Jan 1, 1995·International Journal of Technology Assessment in Health Care·J L Donovan
Mar 1, 1995·American Journal of Epidemiology·V E BovbjergR H Knopp
Sep 1, 1995·Preventive Medicine·L Simkin-SilvermanL H Kuller
May 1, 1996·Journal of General Internal Medicine·G SchectmanA Hartz
Apr 1, 1997·Journal of Internal Medicine·W Insull
Oct 7, 1997·Heart & Lung : the Journal of Critical Care·L A Cofer
Dec 31, 1997·The American Journal of Cardiology·T S Thomas
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Jul 1, 1997·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·L E BurkeM N Hill
Jul 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D S FreedmanJ A Walker
Aug 26, 1998·The American Journal of Medicine·R M Krauss
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Aug 24, 1999·Journal of Cardiopulmonary Rehabilitation·P A AdesR L Carhart
Jan 19, 2000·Circulation·D J MaronM F Linton
Mar 1, 2000·The American Journal of Cardiology·A S Brown, L A Cofer
Mar 1, 2000·The American Journal of Cardiology·K A LaBreshA F Kaul
Aug 1, 1995·Postgraduate Medicine·W Virgil Brown

❮ Previous
Next ❯

Citations

Aug 22, 2009·Journal of Clinical Nursing·Porat NuritZelker Revital

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.